Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?

Satoshi Nori; Christopher S. Ahuja; Michael G. Fehlings

doi:10.1093/neuros/nyx217

Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?

Satoshi Nori, Christopher S. Ahuja, Michael G. Fehlings

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	119-128
Number of pages	10
Journal	Clinical Neurosurgery
Volume	64
Issue number	CN
DOIs	https://doi.org/10.1093/neuros/nyx217
Publication status	Published - 2017 Sept 1
Externally published	Yes

ASJC Scopus subject areas

Surgery
Clinical Neurology

Access to Document

10.1093/neuros/nyx217

Cite this

@article{6c86ed1ad537463bb347d5c56443d0ed,

title = "Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?",

author = "Satoshi Nori and Ahuja, {Christopher S.} and Fehlings, {Michael G.}",

note = "Funding Information: This work is funded by Canadian Institutes of Health Research, AOSpine North America, Rick Hansen Institute, Halbert Chair in Neural Repair and Regeneration, and Dezwirek Foundation. The senior author (MGF) acknowledges support from the Halbert Chair in Neural Repair and Regeneration and the Dezwirek Foundation. Dr Fehlings is a consultant (speaker) for Pfizer and Zimmer Biomed and a consultant for InVivo Therapeutics. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2017",

month = sep,

day = "1",

doi = "10.1093/neuros/nyx217",

language = "English",

volume = "64",

pages = "119--128",

journal = "Clinical Neurosurgery",

issn = "0069-4827",

publisher = "Lippincott Williams and Wilkins",

number = "CN",

}

TY - JOUR

T1 - Translational Advances in the Management of Acute Spinal Cord Injury

T2 - What is New? What is Hot?

AU - Nori, Satoshi

AU - Ahuja, Christopher S.

AU - Fehlings, Michael G.

N1 - Funding Information: This work is funded by Canadian Institutes of Health Research, AOSpine North America, Rick Hansen Institute, Halbert Chair in Neural Repair and Regeneration, and Dezwirek Foundation. The senior author (MGF) acknowledges support from the Halbert Chair in Neural Repair and Regeneration and the Dezwirek Foundation. Dr Fehlings is a consultant (speaker) for Pfizer and Zimmer Biomed and a consultant for InVivo Therapeutics. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85042116661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042116661&partnerID=8YFLogxK

U2 - 10.1093/neuros/nyx217

DO - 10.1093/neuros/nyx217

M3 - Article

C2 - 28899041

AN - SCOPUS:85042116661

SN - 0069-4827

VL - 64

SP - 119

EP - 128

JO - Clinical Neurosurgery

JF - Clinical Neurosurgery

IS - CN

ER -

Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this